Delivery Order SPE2DR25D1202-SPE2DR26F72MQ
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $4,457.88 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a ceiling value of $7,429.80. This is a firm fixed price delivery order with an ultimate completion date of June 25, 2025, awarded on June 3, 2025, and involves no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,429.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside competitive award was issued on September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $17,831.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 17, 2025. This non-set-aside contract was competitively awarded on September 25, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized...
- The Defense Logistics Agency awarded a $1,485.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded on September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized pharmaceutical product...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for pain management in osteoarthritis, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a firm fixed price and no set-aside designation. The order, placed under a competitive award process, is scheduled for completion by September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,991.25 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion deadline of November 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72MQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,631.84 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing at its corporate office location in the same city and serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Zilretta, a corticosteroid injection used for intra-articular knee pain management, represents one specific pharmaceutical product being procured under this larger contract vehicle that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 11/23/25 |